These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1143408)
1. Proceedings: The influence of cardiac glycosides on membrane currents in mammalian myocardium. Nawrath H; McDonald TF; Trautwein W Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R24. PubMed ID: 1143408 [No Abstract] [Full Text] [Related]
2. Relative inotropic and arrhythmogenic effects of five cardiac steroids in ventricular myocardium: oscillatory afterpotentials and the role of endogenous catecholamines. Karagueuzian HS; Katzung BG J Pharmacol Exp Ther; 1981 Aug; 218(2):348-56. PubMed ID: 6114168 [No Abstract] [Full Text] [Related]
3. The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs. Ito M; Hollander PB; Marks BH; Dutta S J Pharmacol Exp Ther; 1970 Mar; 172(1):188-95. PubMed ID: 5416942 [No Abstract] [Full Text] [Related]
4. [Comparative assessment of the action of cardiac glycosides on contractility of the left and right ventricular myocardium in patients with rheumatic heart disease complicated by circulatory insufficiency]. Sivkov II; Lisin VV Sov Med; 1977 Jan; (1):93-7. PubMed ID: 847532 [No Abstract] [Full Text] [Related]
5. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides]. Smielak-Korombel W Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985 [No Abstract] [Full Text] [Related]
6. Proceedings: The effects of cardiac glycosides on Ca-mediated action potentials in the mammalian myocardium. Tritthart H; Weiss R; Volkmann R; Späh F Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R99. PubMed ID: 4276661 [No Abstract] [Full Text] [Related]
7. Sodium dependence of the positive inotropic effect of cardiac glycosides. Wiggins JR; Bentolila JJ J Pharmacol Exp Ther; 1980 Dec; 215(3):569-74. PubMed ID: 7441517 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of therapeutic levels of cardiac glycosides. Noble D Cardiovasc Res; 1980 Sep; 14(9):495-514. PubMed ID: 6163538 [No Abstract] [Full Text] [Related]
9. Proceedings: Inhibitory action of cardiac steroids on the contraction of the taenia coli of the guinea pig--with special respect to the membrane properties of the smooth muscle. Suga T; Suzuki M; Sakai Y Jpn J Pharmacol; 1974; 24(0):s:148. PubMed ID: 4545774 [No Abstract] [Full Text] [Related]
10. Action potential, membrane currents and force of contraction in cat ventricular heart muscle treated with papaverine. Nawrath H J Pharmacol Exp Ther; 1981 Aug; 218(2):544-9. PubMed ID: 7252854 [TBL] [Abstract][Full Text] [Related]
11. [Indications and contraindications for therapy with cardiac glycosides]. Haasis R Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303 [TBL] [Abstract][Full Text] [Related]
12. Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides. Schwartz A; Grupp G; Wallick E; Grupp IL; Ball WJ Prog Clin Biol Res; 1988; 268B():321-38. PubMed ID: 2851810 [TBL] [Abstract][Full Text] [Related]
13. Proceedings: Glycoside inotropy and K+ efflux in presence of an acidosis. Poole-Wilson PA Br Heart J; 1976 Mar; 38(3):320-1. PubMed ID: 1259879 [No Abstract] [Full Text] [Related]
14. [Comparative study of the action of acetylcholine on the transmembrane potentials of the contractile myocardial cells of the ventricles in adult and newborn guinea pigs]. Kobrin VI; Ignatova ED; Klevtsov VA Fiziol Zh SSSR Im I M Sechenova; 1983 Sep; 69(9):1196-9. PubMed ID: 6641998 [TBL] [Abstract][Full Text] [Related]
15. [Effect of drugs on the contractility of the heart]. Greeff K Verh Dtsch Ges Kreislaufforsch; 1976; 42():80-92. PubMed ID: 1007612 [No Abstract] [Full Text] [Related]
16. The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure. Godfraind T Eur Heart J; 1982 Dec; 3 Suppl D():53-7. PubMed ID: 6297911 [No Abstract] [Full Text] [Related]
17. The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Lee KS; Klaus W Pharmacol Rev; 1971 Sep; 23(3):193-261. PubMed ID: 4255625 [No Abstract] [Full Text] [Related]
18. [Pharmacology of isopropylidene-proscillaridin]. Lenke D; Brock N Arzneimittelforschung; 1970 Jan; 20(1):1-7. PubMed ID: 5467444 [No Abstract] [Full Text] [Related]
19. [Cardiac effects, relative enteral effectiveness and rate of inactivation of the cardiac glycoside meproscillarin]. Raschack M; Haas H; Neugebauer G; Sipos J Arzneimittelforschung; 1978; 28(3a):495-502. PubMed ID: 580578 [No Abstract] [Full Text] [Related]
20. Potassium deficiency and cardiac function: experimental and clinical aspects. Lüderitz B Magnesium; 1984; 3(4-6):289-300. PubMed ID: 6536838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]